Species-specific effects of the hepatocarcinogens 3′-methyl-4- dimethyl-aminoazobenzene and ortho-aminoazotoluene in mouse and rat liver

Molecular Carcinogenesis

Volumn 44, Issue 4, 2005, Pages 223-232

  Merkulova, Tatyana I ^a   Kropachev, Konstantin Y ^a   Timofeeva, Olga A ^b,c   Vasiliev, Gennady V ^a   Levashova, Zoia B ^a,c   Ilnitskaya, Svetlana I ^a   Kobzev, Victor F ^a   Pakharukova, Maria Yu ^a   Bryzgalov, Leonid O ^a   Kaledin, Vasily I ^a  

^a INSTITUTE OF CYTOLOGY AND GENETICS   (Russian Federation)

^b INSTITUTE OF CHEMICAL BIOLOGY AND FUNDAMENTAL MEDICINE   (Russian Federation)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Glucocorticoid induction; Hepatocarcinogen; Hepatocyte nuclear factor 3; Species specificity; Tyrosine aminotransferase

Indexed keywords

4 DIMETHYLAMINO 3' METHYLAZOBENZENE; 4 DIMETHYLAMINOAZOBENZENE; 4' METHYL 4 DIMETHYLAMINOAZOBENZENE; AMINOAZOTOLUENE; AMMONIUM SULFATE; CARCINOGEN; DIETHYLNITROSAMINE; GLUCOCORTICOID; HEPATOCYTE NUCLEAR FACTOR 3; MESSENGER RNA; TYROSINE AMINOTRANSFERASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CANCER RESISTANCE; CANCER SUSCEPTIBILITY; CELL NUCLEUS; CONTROLLED STUDY; ENZYME INDUCTION; LIVER CARCINOGENESIS; LIVER CARCINOMA; LIVER HOMOGENATE; MALE; MOUSE; NONHUMAN; PRECIPITATION; PRIORITY JOURNAL; PROTEIN DNA BINDING; RAT; REGULATOR GENE; SPECIES DIFFERENCE; TRANSCRIPTION INITIATION;

ANIMALS; CARCINOGENS; CELL NUCLEUS; DIETHYLNITROSAMINE; ENZYME INDUCTION; GLUCOCORTICOIDS; HEPATOCYTE NUCLEAR FACTOR 3-ALPHA; LIVER; LIVER NEOPLASMS, EXPERIMENTAL; MALE; METHYLDIMETHYLAMINOAZOBENZENE; MICE; O-AMINOAZOTOLUENE; P-DIMETHYLAMINOAZOBENZENE; RATS; RATS, WISTAR; RNA, MESSENGER; SPECIES SPECIFICITY; TYROSINE TRANSAMINASE;

ANIMALIA;

EID: 28844435330     PISSN: 08991987     EISSN: None     Source Type: Journal    
DOI: 10.1002/mc.20090     Document Type: Article

References (47)

1. Silva Lima B, Van der Laan JW. Mechanism of nongenotoxic carcinogens and assessment of the human hazard. Regul Toxicol Pharmacol 2000;32:135-143.
2. Klaunig JE, Kamendulis LM, Xu Y. Epigenetic mechanisms of chemical carcinogenesis. Hum Exp Toxicol 2000;19:571-572.
3. Miller JA, Miller EC. The carcinogenic amino azodyes. Adv Cancer Res 1953;1:339-396.
4. Marhold J, Matrka M, Rambousek V, Ruffer F. Oxidation of carcinogenic azo-dyes. VI. Influence of substitution on the carcinogenic activity of aminoazobenzene. Neoplasma 1969; 16:181-189.
5. Fujii K. Induction of tumors in transplacental or neonatal mice administered 3′-methyl-4-dimethylaminoazobenzene or 4-aminoazobenzene. Cancer Lett 1983;17:321-325.
6. Kaledin VI, Zakharova NP. Effect of hepatocarcinogens on hormonal induction of tyrosine aminotransferase in the liver of sensitive and resistant animals. In: Studies on tumor induction and metastasis in experimental animals. Novosibirsk: IC&G Press; 1984. pp 146-185 (in Russian).
7. Ames BN, Durston WE, Yamasaki E, Lee FD. Carcinogens are mutagens: A simple test system combining liver homogenates for activation and bacteria for detection. Proc Natl Acad Sci USA 1973;70:2281-2285.
8. Victorin K, Busk L, Ahlborg UG. Retinol (vitamin A) inhibits the mutagenicity of o-aminoazotoluene activated by liver microsomes from several species in the Ames test. Mutat Res 1987;179:41-48.
9. Kaledin VI, Gulyaeva LF, Vavilin VA, Makarova SI, Morozkova TS, Richter VA. Activity of drug-metabolising enzymes in the liver of sensitive to hepatocarcinogenic action of orthoaminoazotoluene SWR and C3HA mice and resistant AKR and CC57BRones. Exp Oncol 1999;21:18-23 (in Russian).
10. Zacharova LY, Gulyaeva LF, Lyakhovich VV, et al. Cytochrome P4501A1 and 1A2 gene expression in the liver of methylcholanthrene-and o-aminoazotoluene- treated mice: Comparison between PAH-responsive and PAH-nonresponsive strains. Toxicol Sci 2003;73:108-113.
11. Kizer DE, Cox B, Howell BA, Shirley BC. Effect of hepatocarcinogens on hepatocyte DNA synthesis and cortisone induction of tryptophane oxygenase. Cancer Res 1969;29: 2039-2046.
12. Kaledin VI, Baginskaia NV, Semenova LA. Effect of 3′-methyl-4- dimethylaminoazobenzene and its noncarcinogenic analogs on glucocorticoid induction of tyrosine aminotransferase and alanine aminotransferase in the liver of Sprague-Dawley rats. Exp Oncol 1992;14:43-47 (in Russian).
13. Anderson RA, Raina PN, Milholland RJ. Altered responses to cortisol in precancerous liver. Oncologia 1966;20:153-166.
14. Hanausen-Walaszek M, Schumm DE, Webb TE. The repression and derepression of hepatic tyrosine aminotransferase by carcinogens. Chem Biol Interact 1976;12:391-401.
15. Kensler TW, Busby WF, Davidson NE, Wogan GN. Effect of hepatocarcinogenson the binding of glucocorticoid receptor complex in rat liver nuclei. Cancer Res 1976;36:4647-4651.
16. 1 and sterigmatocystin in Reuber hepatoma cells. Cancer Res 1988;48:5188-5192.
17. Kaledin VI, Glazko TT, Zakharova NP. Impairment of glucocorticoid induction of tyrosine aminotransferase in the liver of mice treated with o-aminoazotoluene. Dokl Acad Nauk SSSR 1979;244:233-237 (in Russian).
18. Merkulova TI, Kaledin VI, Kropachev KIu, Kobzev VF, Vasilev GV. The effect of o-aminoazotoluene on glucocorticoid induction of tyrosine aminotransferase in mice sensitive to its hepatocarcinogenic activity is mediated by transcription factor HNF3gamma. Dokl Akad Nauk 1998;361:700-703 (in Russian).
19. Kropachev KY, Kaledin VI, Kobzev VF, Plisov SY, Levashova ZB, Merkulova TI. Involvement of transcription factor HNF3γ in the effect of o-aminoazotoluene on glucocorticoid induction of tyrosine aminotransferase in mice sensitive to its hepatocarcinogenic action. Mol Carcinog 2001;31:10-15.
20. Nitch D, Boshart M, Schutz G. Activation of the tyrosine aminotransferase gene is dependent on synergy between liver-specific and hormone-responsive elements. Proc Natl Acad Sci USA 1993;90:5479-5483.
21. Espinas ML, Roux J, Ghysdael J, Pictet R, Grange T. Participation of Ets transcription factors in the glucocorticoid response of the rat tyrosine aminotransferase gene. Mol Cell Biol 1994;14:4116-4125.
22. Oshima H, Szapary D, Simons SS. The factor binding to the glucocorticoid modulatory element of the tyrosine aminotransferase gene is a novel and ubiquitous heteromeric complex. J Biol Chem 1995;270:21893-21901.
23. Cereghini S. Liver-enriched transcription factors and hepatocyte differentiation. FASEB J 1996;10:267-282.
24. Hayashi Y, Wang W, Ninomiya T, Nagano H, Ohta K, Itoh H. Liver-enriched transcription factors and differentiation of hepatocellular carcinoma. J Clin Pathol Mol Pathol 1999; 52:19-24.
25. Dragani TA, Manenti G, Colombo BM, Della Porta G. Genetic susceptibility to murine hepatocarcinogens. In: Columbane A, Feo F, Pascale R, Pani P, editors. Chemical carcinogenesis. 2. Modulating factors. New York: Plenum Press; 1991. pp 165-176.
26. Diamondston TI. Assay of tyrosine aminotransferase activity by conversion of p-hydroxyphenilpyruvate to p-hydroxybenzaldehyde. Anal Biochem 1966;16:395-401.
27. Lowry OH, Rosebrough NY, Farr AL, Randall RJ. Protein measurement with Folin phenol reagent. J Biol Chem 1951;193:265-275.
28. Chattopadhyay N, Kher R, Godbole M. Inexpensive SDS/ phenol method for RNA extraction from tissues. Biotechniques 1993;15:24-26.
29. Auboeuf D, Vidal H. The use of reverse transcription-competitive polymerase chain reaction to investigate in vivo regulation of gene expression in small tissue samples. Anal Biochem 1997;245:141-148.
30. Gorski K, Carneiro M, Schibler U. Tissue-specific in vitro transcription from the mouse albumin promoter. Cell 1986;47:767-776.
31. Carey M, Smale ST. Transcriptional regulation in Eukaryotes. Concepts, strategies, and techniques. New York: Cold Spring Harbor; 2000. pp 73-87.
32. Shapiro DJ, Sharp PA, Wahli WW, Keller MJ. A high-efficiency HeLa cell nuclear transcription extract. DNA 1988;7:47-55.
33. Lai E, Prezioso VR, Smith E, Litvin O, Costa RH, Darnell JE. HNF-3A, a hepatocyte-enriched transcription factor of novel structure is regulated transcriptionally. Genes Dev 1990;4:1427-1438.
34. Cereghini S, Raymondjen M, Carranca A, Herbomel P, Yaniv M. A liver-specific factor essential for albumin transcription differs between differentiated and dedifferentiated rat hepatoma cells. Cell 1987;50:627-638.
35. Kumarev VP, Kobzev VF, Kuznedelov KD, Sredin YG. Superrapid synthesis of oligodeoxyribonucleotides on a microscale. Nucleic Acids Sym Ser 1991;24:234.
36. Samadani U, Qian X, Costa RH. Identification of a transthyretin enhancer site that selectively binds the hepatocyte nuclear factor 3β isoform. Gene Expr 1996;6:23-33.
37. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227:680-685.
38. Kropachev KYu, Kaledin VI, Timofeeva OA, et al. The effect of hepatocarcinogen o-aminoazotoluene on induction of mouse liver tyrosine aminotransferase by glucocorticoids. Mol Biol (Mosk) 2001;35:462-469 (in Russian).
39. Miller MS, Buzard GS, McDowell AE. In vivo inhibition of glucocorticoid-indudble gene expression by dimethylnitrosamine in rat liver. Biochem Pharmacol 1993;45:1465-1470.
40. Yeoh GC. The effect of 3′-methyl-4-dimethyl-aminoazobenzene on foetal rat hepatocytes in culture. Eur J Cancer Clin Oncol 1981;17:743-752.
41. Ilnitskaya SI, Vasilieva ED, Kaledin VI. Differences in glucocorticoid induction of tyrosine, alanine, and aspartate aminotransferases and in the effects of hepatocarcinogens on the induction in mice and rats. Bull SD RAMS 1999;3-4:25-28 (in Russian).
42. Roux J, Pictet R, Grange T. Hepatocyte nuclear factor 3 determines the amplitude of the glucocorticoid response of the rat tyrosine aminotransferase gene. DNA Cell Biol 1995; 14:385-396.
43. Nakamura T, Mura T, Saito K, Ohsawa T, Akiyoshi H, Sato K. Adenovirus-transferred HNF3γ conserves some liver functions in primary cultured hepatocytes of adult rats. Biochem Biophis Res Comm 1998;253:352-357.
44. Whitmarsh AJ, Davis RJ. Regulation of transcription factor function by phosphorylation. Cell Mol Life Sci 2000;57: 1172-1183.
45. Kouzarides T. Acetylation a regulatory modification to rival phosphorylation. EMBO J 2000;19:1176-1179;
46. Kliewer SA, Moore JT, Wade L, et al. An orphan nuclear receptor activated by pregnanes defines a novel steroid signalling pathway. Cell 1998;92:73-82.
47. Planque N, Leconte L, Coquelle FM, et al. Interaction of Maf transcription factors with Pax-6 results in synergistic activation of the glucagon promoter. J Biol Chem 2001;278: 35751-35760.